Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
LIC MF Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.9.7248538518.5865
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.794567235.1162
Domestic EquitiesCipla Ltd.5.6196312184.9618
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.2936131304.6740
Domestic EquitiesFortis Healthcare Ltd.4.3464421023.8376
Domestic EquitiesDivi's Laboratories Ltd.4.276461583.7758
Domestic EquitiesPiramal Pharma Ltd.4.12171983853.6392
Domestic EquitiesAlkem Laboratories Ltd.3.731362123.2945
Domestic EquitiesNeuland Laboratories Ltd.3.678624143.2480
Domestic EquitiesAurobindo Pharma Ltd.3.6439313013.2174
Domestic EquitiesAbbott India Ltd.3.45139683.0473
Domestic EquitiesIPCA Laboratories Ltd.2.8711183112.5350
Domestic EquitiesGland Pharma Ltd.2.8298133512.4986
Domestic EquitiesMetropolis Healthcare Ltd.2.8298114172.4986
Domestic EquitiesArtemis Medicare Services Ltd.2.69911088322.3832
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.6134119942.3075
Domestic EquitiesOnesource Specialty Pharma Ltd.2.5882120772.2852
Domestic EquitiesNavin Fluorine International Ltd.2.546147962.2481
Domestic EquitiesDr Agarwal's Health Care Ltd.2.4334496842.1486
Domestic EquitiesMankind Pharma Ltd.2.400785772.1197
Domestic EquitiesConcord Biotech Ltd.2.3505123412.0754
Domestic EquitiesGlobal Health Ltd.2.3268149522.0544
Domestic EquitiesMax Healthcare Institute Ltd.2.1930167751.9363
Domestic EquitiesSyngene International Ltd.2.0033282601.7688
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.1.901497361.6788
Domestic EquitiesAnthem Biosciences Ltd.1.7136184951.5130
Domestic EquitiesVinati Organics Ltd.1.693387411.4951
Domestic EquitiesAcutaas Chemicals Ltd.1.546497111.3654
Domestic EquitiesLinde India Ltd.1.126215590.9944
Total 94.3483 83.3044
Cash & Cash Equivalents and Net AssetsTreps5.7927 5.1146
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1410 -0.1245
Total 5.6517 4.9901
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.